Your session is about to expire
← Back to Search
Tailored Adherence Program for Young Adults with Cancer
N/A
Recruiting
Led By Meghan E McGrady, PhD
Research Sponsored by Children's Hospital Medical Center, Cincinnati
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study enrollment period, approximately 12 months after enrollment initiation
Awards & highlights
Study Summary
This trial will test a tailored program for 40 young adults with cancer to see if it meets criteria and is easy/acceptable to use.
Who is the study for?
This trial is for adolescents and young adults aged 15-24 with cancer who are prescribed oral chemotherapy or prophylactic medication. They must be fluent in English without significant cognitive deficits, as judged by their medical team, and willing to use an electronic monitoring device. Those already showing high adherence (95% or more) during a preliminary period won't qualify.Check my eligibility
What is being tested?
The study tests a tailored program against the standard uniform care to improve medication adherence in young cancer patients. It's designed to see if the new approach is feasible, easy to use, acceptable, and meets certain criteria regarding enrollment, retention, fidelity of implementation, and data completion.See study design
What are the potential side effects?
Since this trial focuses on improving adherence rather than testing new medications, side effects will relate primarily to the existing medications being taken by participants rather than from the interventions themselves.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ end of study enrollment period, approximately 12 months after enrollment initiation
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study enrollment period, approximately 12 months after enrollment initiation
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Enrollment Rate
Secondary outcome measures
Acceptability & Adherence Scale
Adjective Rating Scale
Assessment Completion
+8 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: Tailored ProgramExperimental Treatment1 Intervention
8-week tailored program including 4 coach visits and 4 bi-weekly text check-ins
Group II: Feedback ProgramExperimental Treatment1 Intervention
8-week feedback program including 8 weekly texts
Find a Location
Who is running the clinical trial?
Children's Hospital Medical Center, CincinnatiLead Sponsor
815 Previous Clinical Trials
6,530,630 Total Patients Enrolled
St. Jude Children's Research HospitalOTHER
432 Previous Clinical Trials
5,307,888 Total Patients Enrolled
Seattle Children's HospitalOTHER
306 Previous Clinical Trials
5,218,357 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not fluent in English.I am taking oral chemotherapy or medication to prevent illness.My doctor, caregiver, or I have decided I can't join due to my health or treatment.I choose not to use an electronic monitoring device.I have been diagnosed with cancer.I am between 15 and 24 years old.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Research Study Groups:
This trial has the following groups:- Group 1: Tailored Program
- Group 2: Feedback Program
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger